Tag Archives: About

Viewpoints: Hospitals Come Up Short By Failing To Treat Opioid Use Disorders; Warnings About How Medical Professionals Could Operate In States With Assisted Dying Laws

Opinion writers weigh in on these health topics and others. Stat: Hospitals Are A Missing Link In Easing The Opioid Crisis Nearly half a million individuals with opioid use disorders are hospitalized each year in the United States. While they are in the hospital, medical providers often treat complications of this disorder, such as bloodstream… Read More »

Bluebird CEO defends $1.8 million gene therapy price — ‘It’s really thinking about it differently’

Bluebird Bio CEO Nick Leschly on Friday defended the biotech company’s $ 1.8 million price tag for its new gene therapy to treat a rare genetic blood disorder. Bluebird’s therapy, Zynteglo, was approved in Europe earlier this month for patients with beta thalassemia who require regular blood transfusions to manage their disease and have no… Read More »